Veltuzumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 20:06, 13 June 2009 (No ATC code). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Veltuzumab
Monoclonal antibody
Type?
SourceHumanized
TargetCD20
Clinical data
ATC code
  • none
Identifiers
CAS Number
Chemical and physical data
FormulaC6458H9918N1706O2026S46
Molar mass145.3 kDa g·mol−1

Veltuzumab is a monoclonal antibody used in the treatment of non-Hodgkin's lymphoma.[1]

This drug was developed by Immunomedics, Inc.

References

  1. ^ STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - VELTUZUMAB, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Template:Humanizedmonoclonals

Retrieved from "https://en.wikipedia.org/w/index.php?title=Veltuzumab&oldid=296222750"